Tue.Dec 12, 2023

article thumbnail

Five Ways Preceptors May Integrate Generative Artificial Intelligence Programs Into Pharmacy Education Learning Experiences

IDStewardship

In this article a clinical pharmacist discusses ways that preceptors may integrate generative artificial intelligence programs into pharmacy education for student and resident learning experiences. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Generative artificial intelligence was NOT used to create this text. Although, maybe it would be better if I had used it!

article thumbnail

FDA Approves First Gene Therapies for Treatment in Patients With Sickle Cell Disease

Drug Topics

The approvals mark a turning point in the ongoing effort to manage sickle cell disease, the most common inherited red blood cell disorder in the United States.

FDA 201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MAPS PBC Submits NDA to the FDA for MDMA-Assisted Therapy for PTSD

Pharmacy Times

An FDA approval of 3,4-Methylenedioxy-methamphetamine (MDMA)–assisted therapy would require the Drug Enforcement Administration to reschedule MDMA in acknowledgement of its medical use, making it available for prescription medical use.

FDA 145
article thumbnail

Maternal Cannabis Use During Pregnancy Associated With Adverse Health Outcomes

Drug Topics

A recent study found that cannabis exposure over the course a pregnancy was associated with small-for-gestational-age birth, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Humana used algorithm in ‘fraudulent scheme’ to deny care to Medicare Advantage patients, lawsuit alleges

STAT

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries. The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people

Insurance 145
article thumbnail

Europe names hundreds of critical medicines in quest to counter drug shortages

Fierce Pharma

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. | Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages. Inclusion in the list doesn’t mean a particular drug is likely to experience a shortage anytime soon, the EMA said.

144
144

More Trending

article thumbnail

Study Results Demonstrate Population-Based Effects of SCS on Melanoma Mortality Minimal, Not Significant

Pharmacy Times

The study authors note that low skin cancer screening (SCS) participation, the participants’ better health than nonparticipants, and examination biases may be contributing factors to the insignificant results.

132
132
article thumbnail

Methadone clinics spar with addiction doctors on bill that would widen access

STAT

Lawmakers on Tuesday will debate an addiction medicine proposal that would have been considered unthinkable just years ago: giving a select group of doctors the power to prescribe methadone directly to patients. With no end in sight to the deadly U.S. drug overdose crisis, which claims nearly 110,000 lives a year, many advocates have zeroed in on methadone as a potential game changer.

143
143
article thumbnail

Massachusetts providers, payers axing mental health, prior drug use credentialing questions

Fierce Healthcare

Massachusetts healthcare organizations announced this week that every hospital, health system and local health plan in the state is removing “stigmatizing or invasive” mental health questions from | In a nationwide first, every hospital, health system and local health plan in the state has signed on to removing sensitive mental health questions from physician credentialing processes that advocates say inhibit their ability to seek help.

Hospitals 128
article thumbnail

Boston’s mobile clinics offer model of health care that meets patients where they are

STAT

BOSTON — Chongcan Zhu, an 83-year-old longtime resident of Boston, lives alone — but she doesn’t feel a sense of isolation when it comes to receiving health care. That’s thanks to the van that comes straight to the senior residential community where she lives, providing services to people dealing with conditions like high blood pressure and cholesterol, diabetes, and substance use disorders.

Hospitals 143
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma

Pharmacy Times

These data support the combination of daratumumab plus VRd followed by daratumumab and lenalidomide maintenance as a new standard of care for transplant-eligible patients.

121
121
article thumbnail

Opinion: New sickle cell disease CRISPR treatments can’t make up for the shortage of adult hematologists

STAT

After decades of limited progress in the treatment of sickle cell disease (SCD), both patients and physicians are on the verge of monumental change. On Friday, the Food and Drug Administration approved Vertex/CRISPR Therapeutics’ Casgevy and Bluebird Bio’s Lyfgenia, the first one-time gene therapies that will treat the underlying cause of SCD rather than just the symptoms.

FDA 138
article thumbnail

Practice Better launches AI tool to transcribe sessions, give time back to practitioners

Fierce Healthcare

Practice Better, an all-in-one practice management software platform, has launched its take on an artificial intelligence charting assistant. | The AI tool is intended to give practitioners back critical face time with patients and securely records, transcribes and summarizes client sessions in a practitioner’s charting workflow.

126
126
article thumbnail

Pfizer reveals reorganization, executive departure as it gets ready to close $43B Seagen buyout

Fierce Pharma

To complete its acquisition of Seagen, what did Pfizer need to do to satisfy antitrust concerns of the Federal Trade Commission? | By agreeing to donate royalties on its U.S. sales of bladder cancer drug Bavencio, Pfizer has received the go-ahead to finalize its $43 billion buyout of Seagen, the company said on Tuesday. Pfizer expects to close the merger on Thursday.

126
126
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Study: IL-23 Inhibitors Associated With Lowest Risk of Paradoxical Eczema in Patients With Plaque Psoriasis

Pharmacy Times

Biologics for plaque psoriasis has been associated with an atopic dermatitis phenotype, paradoxical eczema, but the risk factors are not well known.

132
132
article thumbnail

Opinion: It’s time to rethink the Medicare annual wellness visit

STAT

In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV), a new visit type with no cost to Medicare patients, better reimbursement to primary care practices, and higher assigned credit for clinicians’ work. The visit takes about 30 minutes and includes a questionnaire covering home safety, falls risk, and ability to perform activities of daily living, along with a survey of recommended preventive services and depression and dementia screening.

Insurance 124
article thumbnail

Biologic Therapies May Help Minimize Steroid Risks Among Patients With Severe Asthma

Drug Topics

A phase 4 study demonstrated that biologic therapies can control severe asthma while simultaneously helping patients minimize or eliminate harms associated with inhaled corticosteroids.

98
article thumbnail

STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease

STAT

SAN DIEGO — The sickle cell community has for the past few days been buzzing with news of the first-ever approved gene therapies for the devastating disease. Meanwhile, researchers at the American Society of Hematology meeting on Tuesday are reporting advances in a less expensive and more established strategy proven to cure patients: bone marrow transplant.

article thumbnail

Social Determinants of Health May Not Reduce the Likelihood of Receiving Newer Treatments In Some Cases, According to Expert

Pharmacy Times

In a recent study, people who lived in disadvantaged or rural areas were just as likely to receive the second-generation medications as people in urban areas.

122
122
article thumbnail

TEFCA goes live in 'Big Bang' for nationwide health data sharing

Fierce Healthcare

Seven years in the making, a nationwide network to exchange patient data called the Trusted Exchange Framework and Common Agreement is now operational, marking a critical step in establishing unive | Seven years in the making, a nationwide network to exchange patient data called the Trusted Exchange Framework and Common Agreement is now operational, marking a critical step in establishing universal connectivity across providers.

121
121
article thumbnail

STAT+: Maze CEO ‘personally disappointed’ in Sanofi decision to terminate partnership

STAT

When Sanofi terminated its partnership with Maze Therapeutics this week to develop an experimental drug for Pompe disease, Maze CEO Jason Coloma did not learn the news in a conference call with the French pharma giant or even an email. He found out when Sanofi issued a public statement. Responding to the U.S. Federal Trade Commission’s move to block the licensing deal, Sanofi said it disagreed with the agency’s action, but determined that fighting it in court was “not in the

118
118
article thumbnail

Most healthcare provider leaders are eying the door—and many have already heard offers, survey finds

Fierce Healthcare

Healthcare leadership may be more optimistic going into 2024 than the year prior, but more than three in five say they're hoping for greener pastures within the next 12 months, according to a new s | A new poll of provider organization leadership found that 62% are planning a job change within the next 12 months. Nearly four in five say they've been propositioned within the past six months.

118
118
article thumbnail

Genentech elevates interim CEO Ashley Magargee to full-time leadership position

Fierce Pharma

Genentech’s brief leadership interregnum is coming to an end as the company’s interim chief executive, Ashley Magargee, prepares to take a permanent place on the throne. | Genentech veteran Ashley Magargee, who was tapped to temporarily steer the Roche subsidiary in November, will don the mantle of full-time CEO on Jan. 1, 2024. The executive move comes amid a period of C-suite fluidity for Roche and its large pharma group.

118
118
article thumbnail

Optum Rx rolls out new weight management program

Fierce Healthcare

Optum Rx is launching a new weight management program aimed at improving outcomes and addressing affordability. | Optum Rx is launching a new weight management program aimed at improving outcomes and addressing affordability.

116
116
article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment.

article thumbnail

Drug Sequence Might Not Significantly Impact Survival Outcomes of Patients with Lymphoma

Pharmacy Times

However, a survival benefit was observed with using a signaling inhibitor in general for patients with angioimmunoblastic T-cell lymphoma.

123
123
article thumbnail

STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients

STAT

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients. The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic

112
112
article thumbnail

Health costs have grown steadily with inflation: report

Fierce Healthcare

On the heels of price transparency legislation gaining momentum in Congress, software platform Turquoise Health today revealed data showing health costs did not grow faster than the rate of inflati | Healthcare costs, perhaps surprisingly, have not exceeded the rate of inflation. But the payer reimbursement rate to providers for certain services can still vary greatly, price transparency data shows.

108
108
article thumbnail

STAT+: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug

STAT

SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now results from a late-stage trial announced Tuesday during this year’s meeting of the American Society of Hematology offer evidence to support broader use of the drug. In the Phase 3 trial, known as Perseus, newly diagnosed patients about to receive an infusion of their own blood stem cells were randomly assigned a standard three-drug treatment or the same cocktail with the ad

article thumbnail

Target eases last-minute holiday shopping with Christmas Eve availability of same-day services

Drug Store News

Shoppers will be able to place orders as late as 6 p.m. local time at most stores on Christmas Eve and obtain their items using same-day services, including drive-up and pickup.

105
105
article thumbnail

COVID-19 Vaccines Crucial to Protect Vulnerable Populations During Holiday Season

Drug Topics

A Q&A with Robert Walker, MD, senior vice president and chief medical officer at Novavax.

Vaccines 123
article thumbnail

Can you take ibuprofen while pregnant?

The Checkup by Singlecare

People often talk about the glow that pregnant women get, but the reality of pregnancy is often a little less romantic. During pregnancy, women can and often do experience all sorts of aches and pains from carrying around a little—or a lot—of extra weight. Plus, they’re not immune to regular old headaches. Unfortunately, during pregnancy, you can’t just pop over-the-counter painkillers like ibuprofen to knock out back pain or headaches like you did before.

article thumbnail

Remote Reliance: The Rise of Oncology Home Care

PharmExec

While hurdles remain, home healthcare could deliver better patient-centered cancer care—providing improved outcomes, enhanced quality of life, and reduced strain on resources.

105
105
article thumbnail

Belly button infections: Symptoms, treatments, and prevention

The Checkup by Singlecare

Surely, you have heard of an ear infection or a sinus infection , but have you ever heard of a belly button infection? The belly button, or navel, is a tiny, often overlooked part of the body. The belly button is the spot where babies connect to their mothers by the umbilical cord during pregnancy. Fun fact: about 90% of people have “innies.” And about 10% of people have “outies,” which are due to extra scar tissue or umbilical hernias.